Group One Trading
APRE icon

Group One Trading’s Aprea Therapeutics APRE Stock Holding History

Group One Trading’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-90
Closed -$1K – 7508
2022
Q2 		$1K Sell
90
-5
-5% -$115 ﹤0.01% 7507
2022
Q1 		$4K Sell
95
-15
-14% -$615 ﹤0.01% 7510
2021
Q4 		$6K Sell
110
-540
-83% -$47.7K ﹤0.01% 7558
2021
Q3 		$66K Sell
650
-55
-8% -$5K ﹤0.01% 6309
2021
Q2 		$69K Buy
+705
New +$65.1K ﹤0.01% 6300

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's APRE Position: Q1 2026 in Review

Group One Trading held its Aprea Therapeutics (APRE) position steady in Q1 2026 at 577 shares worth $440. The position accounts for ﹤0.01% of the portfolio, ranked #7331.

Group One Trading first reported a position in APRE in Q1 2021 and has held it in 21 quarters since. The position peaked at $372K in Q3 2021. 22 funds tracked by Wall St. Rank hold APRE as of Q1 2026.

  • Group One Trading held 577 shares of Aprea Therapeutics worth $440 as of Q1 2026.
  • Group One Trading left its Aprea Therapeutics share count unchanged in Q1 2026.
  • Aprea Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7331 holding.
  • Group One Trading first reported a position in Aprea Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Group One Trading's Aprea Therapeutics position peaked at $372K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.